Ibm Retirement Fund Catalent, Inc. Transaction History

Ibm Retirement Fund

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 20, 2022	SELL	$87.2 - $114.05 $235,440 - $307,935	-2,700 Closed	0 $0
Q4 2021 Jan 19, 2022	SELL	$119.57 - $139.07 $227,422 - $264,511	-1,902 Reduced 41.33%	2,700 $346,000
Q3 2021 Oct 05, 2021	BUY	$109.17 - $142.35 $3,275 - $4,270	30 Added 0.66%	4,602 $612,000
Q2 2021 Jul 12, 2021	SELL	$100.34 - $115.69 $100,841 - $116,268	-1,005 Reduced 18.02%	4,572 $494,000
Q1 2021 Apr 22, 2021	SELL	$101.51 - $125.27 $44,867 - $55,369	-442 Reduced 7.34%	5,577 $587,000
Q4 2020 Jan 25, 2021	BUY	$85.88 - $105.36 $67,244 - $82,496	783 Added 14.95%	6,019 $626,000
Q3 2020 Oct 16, 2020	BUY	$72.74 - $92.5 $119,875 - $152,440	1,648 Added 45.93%	5,236 $449,000
Q2 2020 Jul 08, 2020	BUY	$48.02 - $79.04 $172,295 - $283,595	3,588 New	3,588 $263,000

16.5M

10.7K

4.5K

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Ibm Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on Ibm Retirement Fund with notifications on news.